Joint Venture Announcement of ECLEVAR and QUINTEN forming ECLEVAR

MedTech

Paris, France, October 01, 2020 --(PR.com)-- ECLEVAR and QUINTEN announced today the formation
of the joint venture ECLEVAR MedTech, a medical device contract research organization (CRO)
specializing in regulatory compliance and real world evidence post-market solutions.

Driven by its innovative data science and machine learning capabilities, ECLEVAR MedTech provides
medical device manufacturers with cost-effective solutions to comply with Medical Device Regulations
(MDR) to bring safer medical devices to patients.

ECLEVAR is a full-service medical device CRO and was founded in 2018. QUINTEN is a pioneering
French company in Pharma Data Science founded in 2008. QUINTEN has successfully completed several
hundred projects for more than one hundred clients.

ECLEVAR MedTech’s global team is focused on advancing and accelerating the development of medical
devices by utilizing the potential of artificial intelligence (AI) technologies including the monitoring and
synthesis of scientific literature to create Clinical Evaluation Reports (CERs) and generating real world
data necessary for Post-Market Clinical Follow-up (PMCF) reports.

ECLEVAR MedTech’s headquarter is in Paris, France. Expansions are planned to operate throughout
Europe and the United States. The company will be led by its CEO Frederic Couriol, COO Chems
Hachani and CMD Lucas Davy.

For more information, please visit www.eclevarmedtech.com

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
ECLEVAR MedTech
Camille Levita
+33 1 45 74 33 05
Contact via Email
www.eclevarmedtech.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/822241

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use